History of passive antibody administration for prevention and treatment of infectious diseases

Current Opinion in HIV and AIDS
Barney S Graham, Donna M Ambrosino

Abstract

We describe the history of passive immunization to provide context for the series of articles to follow. The history of passive immunization with antibodies to prevent or treat infectious diseases is a story of different eras. There was an extraordinary era of discovery and clinical implementation before the chemical nature of antibodies was even known. This empirical process provided the resources and reagents used to describe and characterize humoral immunity, better define the chemical properties and structure of antibodies, and extend the clinical use of immunoglobulin products to treat or prevent multiple viral and bacterial diseases over the ensuing several decades. The next distinct era came with the discovery of processes to produce monoclonal antibodies (mAbs), and development of more specific therapies. Interestingly, mAb technology resulted in many products to treat autoimmune and allergic diseases, but only one common infectious disease, respiratory syncytial virus, and only in a restricted population of high-risk infants. The current era began in 2003 with a series of publications demonstrating processes for rapidly producing human mAbs. This technology combined with new sequencing technology, advances in structura...Continue Reading

References

Apr 1, 1984·Scandinavian Journal of Immunology·J Lindenmann
Aug 1, 1994·Antimicrobial Agents and Chemotherapy·A Casadevall, M D Scharff
Jan 1, 1994·Antiviral Research·D A Enria, J I Maiztegui
Mar 7, 2002·Microbes and Infection·Florian Winau, Rolf Winau
Dec 14, 2002·Science·Nadia L BernasconiAntonio Lanzavecchia
Aug 16, 2003·Science·Hedda WardemannMichel C Nussenzweig
Sep 27, 2005·The Journal of Antimicrobial Chemotherapy·Kuo-Ming YehFeng-Yee Chang
Dec 7, 2007·Antiviral Research·Delia A EnriaZaida Sánchez
Jun 30, 1923·The Journal of Experimental Medicine·M Heidelberger, O T Avery
Aug 31, 1924·The Journal of Experimental Medicine·M Heidelberger, O T Avery
Oct 26, 1946·Journal of the American Medical Association·H E ALEXANDER, G LEIDY

❮ Previous
Next ❯

Citations

Jan 19, 2016·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·O GarraudS Laperche
Aug 25, 2015·Bulletin de la Société de pathologie exotique·N E EssombaY Coppieters
Oct 28, 2016·Human Vaccines & Immunotherapeutics·Elisabeth K NyakaturaJonathan R Lai
Jan 31, 2017·Immunological Reviews·Amarendra PeguNancy L Haigwood
Jan 31, 2018·Nature Reviews. Immunology·Laura M Walker, Dennis R Burton
Apr 24, 2018·Human Vaccines & Immunotherapeutics·Yunda HuangPeter B Gilbert
Nov 15, 2017·PLoS Medicine·Lynn Morris, Nonhlanhla N Mkhize
Dec 14, 2017·Frontiers in Immunology·Casey K Hua, Margaret E Ackerman
Dec 16, 2017·Scientific Reports·Stephen Albert JohnstonChris W Diehnelt
Sep 20, 2018·Human Vaccines & Immunotherapeutics·Aymn Talat AbbasEsam Ibraheem Ahmed Azhar
Jan 28, 2020·Annual Review of Medicine·Shelly T Karuna, Lawrence Corey
Jul 10, 2019·Scientific Reports·Emilie BrancheSujan Shresta
Jul 10, 2020·Journal of Clinical Apheresis·Tuğçe Nur YiğenoğluFevzi Altuntaş
Jun 17, 2020·Experimental and Therapeutic Medicine·Carolina ConstantinDemetrios A Spandidos
Mar 30, 2017·Current HIV/AIDS Reports·Jinal N Bhiman, Rebecca M Lynch
Dec 9, 2017·Statistical Communications in Infectious Diseases·Peter B GilbertLawrence Corey
Aug 15, 2018·Human Antibodies·Patrick Mayrhofer, Renate Kunert
May 12, 2020·Frontiers in Microbiology·Longping V TseRalph S Baric
Jan 11, 2019·Expert Review of Anti-infective Therapy·Thomas R LawsDiane Williamson
Jul 20, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Burton E BarnettE John Wherry
Mar 3, 2017·Bulletin of the World Health Organization·Erin SparrowSiranda Torvaldsen
Oct 23, 2018·Therapeutic Advances in Vaccines and Immunotherapy·Rajesh KumarJayanta Bhattacharya
Apr 13, 2017·Frontiers in Microbiology·Abdullah F U H SaeedShihua Wang
Aug 16, 2019·Applied Microbiology and Biotechnology·Leila RahbarniaSayna Toraby
Oct 10, 2020·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Bettina KlugIsabel Trebesch
Feb 2, 2021·The Journal of Biological Chemistry·Youjia GuoKensaku Murano
Dec 3, 2020·Risk Management and Healthcare Policy·Nandeeta SamadMainul Haque
Oct 5, 2020·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Fevzi AltuntasOsman Celik
Feb 16, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Srilatha EdupugantiUNKNOWN HVTN 704/HPTN 085 study group
Dec 6, 2020·Seminars in Immunology·Simone PecettaAnja Seubert
Apr 28, 2021·Hematology, Transfusion and Cell Therapy·Sumit Saha, Sachin Kadam
Jun 3, 2021·Antioxidants·Alessio Danilo InchingoloFrancesco Inchingolo

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

Respigam

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Argentine Hemorrhagic Fever

Argentine hemorrhagic fever (AHF) is an endemo-epidemic disease caused by junín virus (JUNV), a member of the arenaviridae family. Discover the latest research on AHF here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.